Radiomic analysis of the peritumoral zone identifies imaging signatures of glioma invasion associated with HSP70 expression - Top-Institutions - MDSpire

Radiomic analysis of the peritumoral zone identifies imaging signatures of glioma invasion associated with HSP70 expression

  • By

  • Natalia Mikhailova

  • Anastasiia Nechaeva

  • Danila Bobkov

  • Hem Chandra Jha

  • Kadambari KV

  • Yerramneni Vamsi Krishna

  • Hari Ponnamma Rani

  • Aleksander Kim

  • Maxim Shevtsov

  • June 12, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Neuro-Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Neuro-Oncology

  • #3

    Almazov Medical Research Center
    Almazov Medical Research Center

    Saint Petersburg, Russia

    Key Differentiators

    • Oncology

  • #4

    Dusseldorf Central Nervous System Tumor Tissue Bank
    Dusseldorf Central Nervous System Tumor Tissue Bank

    Dusseldorf, Germany

    Key Differentiators

    • Oncology

  • #5

    EORTC 1419 ETERNITY study
    EORTC 1419 ETERNITY study

    Brussels, Belgium

    Key Differentiators

    • Oncology

Original Source(s)

Radiomic analysis of the peritumoral zone identifies imaging signatures of glioma invasion associated with HSP70 expression

  • by Natalia Mikhailova, Anastasiia Nechaeva, Danila Bobkov, Hem Chandra Jha, Kadambari KV, Yerramneni Vamsi Krishna, Hari Ponnamma Rani, Aleksander Kim, Maxim Shevtsov

  • June 12, 2026

Related Content

A multicenter clinical study on transanal endoscopic sphincter-preserving resection of low rectal tumors

Research progress on the etiology and pathogenesis of pancreatic cancer: a narrative review

Immune - cell death index in hepatocellular carcinoma: a multi-omics and machine learning study for prognosis and immunotherapy prediction